首页 / 院系成果 / 成果详情页

PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma  期刊论文  

  • 编号:
    e01bcc0f-8352-44fb-87e9-22c53f0013db
  • 作者:
  • 语种:
    English
  • 期刊:
    MEDICAL ONCOLOGY ISSN:1357-0560 2015 年 32 卷 8 期 ; AUG
  • 收录:
  • 关键词:
  • 摘要:

    The incidence of kidney cancer has been increasing globally during the past two decades. Renal cell carcinoma (RCC) is the most aggressive subtype of kidney cancer, which usually deteriorates with epithelial-mesenchymal transition (EMT) that facilitates the migration and invasion of cancer cells. Till now, the underlying mechanism remains unclear. In this study, we demonstrated that programmed death ligand 1 (PD-L1/B7-H1/CD274) could induce EMT and enhance RCC cell cancer stemness through up-regulation of SREBP-1c. Furthermore, we found that PD-L1 is up-regulated in human RCC metastases. These results, taken together, provide evidence for a novel mechanism of PD-L1 in RCC progression, suggesting that there is a close relationship between EMT and immune escape signaling pathways in RCC.

  • 推荐引用方式
    GB/T 7714:
    Wang Yiwei,Wang Hang,Zhao Qi, et al. PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma [J].MEDICAL ONCOLOGY,2015,32(8).
  • APA:
    Wang Yiwei,Wang Hang,Zhao Qi,Xia Yu,&Guo Jianming.(2015).PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma .MEDICAL ONCOLOGY,32(8).
  • MLA:
    Wang Yiwei, et al. "PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma" .MEDICAL ONCOLOGY 32,8(2015).
浏览次数:4 下载次数:0
浏览次数:4
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部